Date published: 2025-9-11

001 800-1338-3838

SCBT Portrait Logo
Seach Input

FLJ20433 활성제

The nomenclature FLJ20433 Activators implies a theoretical group of chemical compounds devised to enhance the activity of the protein encoded by the FLJ20433 gene. The FLJ acronym typically denotes full-length long Japan, a naming convention arising from a project aimed at discovering full-length long cDNA sequences in the Japanese population. Activators is purely speculative and does not correspond to any known chemical class. Should such a protein exist and be identified, activators would be molecules that interact with this protein to upregulate its function. These activators could potentially work by a variety of mechanisms, such as binding to the protein to stabilize its active form, increasing its expression through transcriptional regulation, or enhancing its interaction with other cellular components. The specific chemical properties of FLJ20433 Activators would depend significantly on the tertiary and quaternary structure of the FLJ20433 protein, as well as its role within the cellular machinery.

In the scenario of FLJ20433 Activators' development, the first step would be to ascertain the biological function of the FLJ20433 protein. This would likely entail a combination of genomic, proteomic, and bioinformatic techniques to map out the protein's structure, its domains of activity, and its cellular localization. Understanding the protein's role within the cell would be pivotal, and this could involve delving into its involvement in cellular processes, its interaction networks, and its regulation both at the genetic and post-translational levels. Once a comprehensive understanding of FLJ20433 is obtained, attention would turn to the chemical design of activators. These activators would be synthesized based on the structure of the protein and predicted interaction sites using computational chemistry and molecular modeling. The design process would also draw on knowledge from related proteins or homologous systems, where available. Subsequent experimental phases would involve in vitro and in vivo assays to test the compounds' efficacy in activating the FLJ20433 protein. These assays would measure not only the binding affinity and specificity of the activators but also their capacity to modulate the protein's activity in a controlled manner. Through this iterative process of hypothesis, design, synthesis, and testing, a class of FLJ20433 Activators could potentially be produced, offering insight into the biological function of the protein and serving as molecular probes for further scientific inquiry.

더보기

제품명CAS #카탈로그 번호 수량가격引用RATING

Hydroxyurea

127-07-1sc-29061
sc-29061A
5 g
25 g
$76.00
$255.00
18
(1)

리보뉴클레오티드 환원 효소를 억제하여 DNA 손상을 유발하고, 잠재적으로 EXD3를 포함한 DNA 복구 효소를 유도합니다.

Cisplatin

15663-27-1sc-200896
sc-200896A
100 mg
500 mg
$76.00
$216.00
101
(4)

DNA 부가물을 형성하여 DNA 손상을 유발하고 EXD3와 같은 DNA 복구 단백질을 상향 조절할 수 있습니다.

Etoposide (VP-16)

33419-42-0sc-3512B
sc-3512
sc-3512A
10 mg
100 mg
500 mg
$32.00
$170.00
$385.00
63
(1)

토포이소머라제 II를 억제하여 DNA 가닥이 끊어지도록 유도하여 DNA 복구 효소의 발현을 향상시킬 수 있습니다.

Methyl methanesulfonate

66-27-3sc-250376
sc-250376A
5 g
25 g
$55.00
$130.00
2
(2)

알킬화제는 DNA 손상을 유발하여 EXD3를 포함한 DNA 복구 경로의 발현을 잠재적으로 유발합니다.

Doxorubicin

23214-92-8sc-280681
sc-280681A
1 mg
5 mg
$173.00
$418.00
43
(3)

안트라사이클린은 DNA에 결합하여 손상을 일으키고 DNA 복구 메커니즘을 유도할 수 있는 항생제입니다.

Mitomycin C

50-07-7sc-3514A
sc-3514
sc-3514B
2 mg
5 mg
10 mg
$65.00
$99.00
$140.00
85
(5)

DNA를 교차 연결하여 EXD3 발현을 포함한 DNA 복구 활동을 증가시킵니다.

Camptothecin

7689-03-4sc-200871
sc-200871A
sc-200871B
50 mg
250 mg
100 mg
$57.00
$182.00
$92.00
21
(2)

토포이소머라제 I을 억제하여 DNA 파손을 유발하고 EXD3와 같은 DNA 복구 효소를 상향 조절할 수 있습니다.

Bleomycin

11056-06-7sc-507293
5 mg
$270.00
5
(0)

DNA 분열을 유도하여 EXD3와 같은 DNA 복구에 관여하는 유전자의 발현을 잠재적으로 증가시킵니다.

Benzo[a]pyrene

50-32-8sc-257130
1 g
$439.00
4
(1)

다환 방향족 탄화수소로 DNA 부가체를 형성하여 잠재적으로 DNA 복구 유전자의 발현을 유도합니다.

Acrylamide Solution, 40%

79-06-1sc-3721
1 L
$98.00
(1)

DNA 부가물을 형성하여 유전체 손상을 유발할 수 있으며, 잠재적으로 EXD3 발현을 포함한 DNA 복구 메커니즘을 상향 조절할 수 있습니다.